Education
About Us
Working with TipRanks
Follow Us
Dr. Hoenle AG (GB:0O27)
LSE:0O27
0O27 Stock Chart & Stats
€8.12
-€0.14(-1.99%)
At close: 4:00 PM EST
€8.12
-€0.14(-1.99%)
Day’s Range― - ―
52-Week Range€6.70 - €11.70
Previous CloseN/A
Volume1.10K
Average Volume (3M)689.00
Market Cap
€61.22M
Enterprise Value€101.75M
Total Cash (Recent Filing)€7.75M
Total Debt (Recent Filing)€49.25M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
May 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.25
Shares Outstanding6,062,930
10 Day Avg. Volume2,033
30 Day Avg. Volume689
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)0.65
Price to Sales (P/S)0.53
P/FCF Ratio15.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Operating Improvement (2025)A clear narrowing of the EBIT loss and improved EBITDA margin in 2025 suggests operational fixes or mix shifts that are already driving unit economics higher. If the improvements reflect structural cost control and better product mix, they can sustainably reduce cash burn and enable a path to durable profitability over coming quarters.
Positive Free Cash Flow TrendConsecutive positive operating and free cash flow from 2023 through 2025 indicates the business can generate internal funding despite prior losses. Sustained FCF strengthens the company's ability to fund maintenance capex, spare parts inventory and selective investments without recurrent external financing, supporting longer-term operational resilience.
Manageable Leverage And Declining DebtDeclining total debt and moderate debt-to-equity provide balance-sheet flexibility to withstand cyclical industrial capex patterns. A manageable leverage profile reduces refinancing risk, helps preserve investment capacity for product development and aftermarket support, and limits downside from temporary demand weakness.
Bears Say
Multi-year Revenue DeclineA persistent revenue downtrend erodes scale advantages and reduces recurring aftermarket demand tied to installed systems. Continued top-line contraction makes it harder to cover fixed costs, pressures margins and limits the firm's ability to invest in R&D, sales coverage and service capabilities that drive long-term growth.
Persistent Net LossesSustained negative net margins and recurring losses weaken equity returns and can gradually erode capital buffers. Without durable profitability, the company risks constrained reinvestment, reduced ability to scale aftermarket revenue, and ongoing reliance on cash conservation measures that could hamper long-term competitiveness.
Volatile Cash Generation HistoryIntermittent negative operating and free cash flow in prior years shows cash generation is sensitive to demand swings and working-capital timing. Such volatility raises the risk of episodic funding needs, complicates multi-year planning for capex and product programs, and could increase reliance on external financing in downturns.
Dr. Hoenle AG News
0O27 FAQ
What was Dr. Hoenle AG’s price range in the past 12 months?
Dr. Hoenle AG lowest share price was €6.70 and its highest was €11.70 in the past 12 months.
What is Dr. Hoenle AG’s market cap?
Dr. Hoenle AG’s market cap is €61.22M.
When is Dr. Hoenle AG’s upcoming earnings report date?
Dr. Hoenle AG’s upcoming earnings report date is May 13, 2026 which is in 76 days.
How were Dr. Hoenle AG’s earnings last quarter?
Dr. Hoenle AG released its earnings results on Feb 24, 2026. The company reported -€0.25 earnings per share for the quarter, missing the consensus estimate of -€0.211 by -€0.039.
Is Dr. Hoenle AG overvalued?
According to Wall Street analysts Dr. Hoenle AG’s price is currently Overvalued.
Does Dr. Hoenle AG pay dividends?
Dr. Hoenle AG pays a Annually dividend of €0.2 which represents an annual dividend yield of N/A. See more information on Dr. Hoenle AG dividends here
What is Dr. Hoenle AG’s EPS estimate?
Dr. Hoenle AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Dr. Hoenle AG have?
Dr. Hoenle AG has 6,062,930 shares outstanding.
What happened to Dr. Hoenle AG’s price movement after its last earnings report?
Dr. Hoenle AG reported an EPS of -€0.25 in its last earnings report, missing expectations of -€0.211. Following the earnings report the stock price went up 8.421%.
Which hedge fund is a major shareholder of Dr. Hoenle AG?
Currently, no hedge funds are holding shares in GB:0O27
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Dr. Hoenle AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-5.78%
12-Months-Change
Fundamentals
Return on Equity
-15.84%
Trailing 12-Months
Asset Growth
-11.57%
Trailing 12-Months
Company Description
Dr. Hoenle AG
Dr. Hönle AG supplies industrial UV technologies and systems in Germany and internationally. The company operates through three segments: Adhesives, Equipment & Systems, and Glass & Lamps. The Adhesives segment provides industrial adhesives for applications, such as consumer electronics, medical technology, optics and opto electronics, automotive, and glass processing. The Equipment & Systems segment engages in the drying of inks and coatings, curing of adhesives and plastics, disinfecting surfaces, and solar simulation. The Glass & Lamps segment offers quartz glass tubing and rods for the lamp, automotive, semiconductor, and fibre cable industries, as well as lamps for water disinfection, and the drying of coatings and adhesives. The company was founded in 1976 and is headquartered in Munich, Germany.
Technical Analysis
Options Prices
Currently, No data available
---